Computed Tomography Market Size Analysis 2022 To 2030

The global computed tomography market size accounted for US$ 7.9 billion in 2021 and is projected to reach around USD 10.2 billion by 2030, growing at a CAGR of 6.5% from 2022 to 2030.

Computed Tomography Market Key Takeaways:

• By technology, the high-end slice (more than 64 slices) segment reached highest market share of over 35.4% in 2021.
• The CBCT segment is growing at a strongest CAGR over the forecast period.
• By application, the oncology segment has accounted market share of over 26.9% in 2021.
• By end user, the hospitals & clinic segment has contributed 49% market share in 2021.
• North America has held market share of over 30.6% in 2021.
• The Asia Pacific market is expected to witness a highest CAGR from 2022 to 2030.

Report Summary

The global computed tomography market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the computed tomography market across the globe.

A comprehensive estimate on the computed tomography market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of computed tomography during the forecast period. Price point comparison by region with global average price is also considered in the study.

Computed Tomography Market Scope

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized computed tomography market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Electric Vehicles Engineering Plastics Market Size Analysis 2022 To 2030

Computed Tomography Market Players

The report includes the profiles of key computed tomography market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area are Fujifilm Corporation, Planmeca Oy, Carestream Health, Canon Medical Systems corporation, Neusoft Medical Systems, Koninklijke Philips, Siemens Healthineers, Hitachi, Ltd, GE Healthcare, NeuroLogica Corp, Shenzhen Anke High-Tech Co

Market Segmentation

By Technology

• High slice
• Mid slice
• Low slice
• Cone beam

By Application

• Neurology
• Orthopedics
• Oncology
• Cardiovascular
• Respiratory
• Gastrointestinal
• Others

By Modality

• O arm
• C arm

By End-User 

• Hospitals
• Ambulatory surgery centers
• Health clinics
• Diagnostics imaging centers
• Others

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Computed Tomography Market 

5.1. COVID-19 Landscape: Computed Tomography Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Computed Tomography Market, By Technology

8.1. Computed Tomography Market, by Technology, 2022-2030

8.1.1. High slice

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Mid slice

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Low slice

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Cone beam

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Computed Tomography Market, By Application

9.1. Computed Tomography Market, by Application, 2022-2030

9.1.1. Neurology

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Orthopedics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Oncology

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Oncology

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Respiratory

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.5. Gastrointestinal

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Computed Tomography Market, By Modality 

10.1. Computed Tomography Market, by Modality, 2022-2030

10.1.1. O arm

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. C arm

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Computed Tomography Market, By End-User 

11.1. Computed Tomography Market, by End-User, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Ambulatory surgery centers

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Health clinics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Diagnostics imaging centers

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Computed Tomography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.4. Market Revenue and Forecast, by End-User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.4. Market Revenue and Forecast, by End-User犀利士
(2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 13. Company Profiles

13.1. Fujifilm Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Planmeca Oy

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Carestream Health

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Canon Medical Systems corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Neusoft Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Koninklijke Philips

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Siemens Healthineers

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Hitachi, Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GE Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. NeuroLogica Corp

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2221

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com